Chipscreen 微芯生物
20 significant filings since 31 May 2026: 13 on equity incentive, 4 on share issue and 3 on buyback. The latest, on 26 Aug 2026: 关于2024年度向特定对象发行股票限售股上市流通的公告.
自 31 May 2026 起有 20 份重大公告：equity incentive 13 份、share issue 4 份、buyback 3 份。最新一份（26 Aug 2026）：关于2024年度向特定对象发行股票限售股上市流通的公告。
Price History 价格走势
1 session 个交易日, Mon 28 Sep 2026 · Live one-minute prices 实时分钟价格 · High 最高 ¥25.40 · Low 最低 ¥24.83 · −0.55% on the previous close of ¥25.35 较昨收The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 太平洋 | 谭紫媚,张懿 | Buy 买入 | 6 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 1 report. 每行为该券商近十二个月的最新研报；1 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。